Biocure Technology Inc.
OTC: BICTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yee Sing Cheng
- Headquarters
- Vancouver, Canada
- IPO year
- 2018
- Market cap
- $379.1K
- Website
- https://www.biocuretech.com
Loading BICTF…
Loading profile data…Frequently asked questions about BICTF
What does Biocure Technology Inc. (BICTF) do?
Biocure Technology Inc., along with its subsidiary, is dedicated to the development and market introduction of biopharmaceutical technologies, particularly those leveraging recombinant proteins and ranibizumab. The company's therapeutic pipeline features Interferons-ß, which are being advanced for the treatment of multiple sclerosis. They are al...
Where does BICTF trade?
Biocure Technology Inc. (BICTF) trades on the Other OTC.
What sector is BICTF in?
Biocure Technology Inc. (BICTF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biocure Technology Inc.?
Yee Sing Cheng is the chief executive officer of Biocure Technology Inc. (BICTF).
Where is Biocure Technology Inc. headquartered?
Biocure Technology Inc. is headquartered in Canada.
Does BICTF pay a dividend?
Biocure Technology Inc. (BICTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BICTF go public?
Biocure Technology Inc. (BICTF) completed its initial public offering in 2018.